HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume  

 

 

If you want to download the journal, please login or register as reader.

2023 Issues

Cover

Vol. 25 • Na. N1 • February 2023

In this issue:

  • The assessment of blood homocysteine and S100B levels in patients with opioid use disorders
    Yıldırım Ozbek S., Inanlı İ., Eren I., Cicek E., Ozbek S., Kurku H., Demirel B., Cicek İ.E., and Uygur H.
  • Previously Used Substances and Predictors of Illicit Drug Use among Incarcerated Male Prisoners in Galle, Sri Lanka
    Darshana N., Ruben R., and Wijesinghe C.
  • Neonatal Abstinence Syndrome in Vojvodina, Serbia: Infant and Maternal Characteristics
    Mijatović Jovin V., Vejnović A., Knezović G., Pavlović V., Vejnović A.-M., and Dickov I.
  • The role of biopsychological factors in relapse of patients undergoing Methadone Maintenance Treatment in Iran
    Motazedian S., Kheradmand A., Badiei R., Seif P., and Danesh A.
  • Artistic clues to the diagnosis of bipolar dual disorder in opioid addicts. The case of Nachtmystium
    Pacini M., and Maremmani I.

 

Cover

Vol. 25 • Na. N2 • April 2023

In this issue:

  • The effect of Raha syrup on the development of morphine tolerance and dependence on rats
    Haerifar F., Zahedi-Khorasani M., Ghanbari A., and Miladi-Gorji H.
  • The impact of COVID-19 pandemic on pregnant women with Substance Use Disorder (SUD): a narrative review
    Caglioni M., Ragona A., Maremmani A.G.I., Silvia C., and Cerniglia L.
  • Maternal Methadone Split Dosing in Pregnancy
    Flores C., and Riaz U.
  • CYP genetic polymorphism, pharmacokinetics of methadone, and the biggest risks
    Jovanovic M., Bozovic N., Rancic N., Pjevac A., Rascanin S., and Stojkovic M.
  • Insight in dual disorder heroin addicts. Are they able to request adequate treatment?
    Pacini M., Maremmani A.G.I., Della Rocca F., Miccoli M., and Maremmani I.

 

Cover

Vol. 25 • Na. N3 • June 2023

In this issue:

  • Positive Psychology as a Protective Factor for Illicit Opioids in Individuals Receiving Methadone Treatment.
    Krembuszewski B., Anderson-White E., Henderson C., White S., and Langley H.
  • Effect of Raha Syrup on the Severity of Dependence, Depression, Anxiety, Stress, Craving and Serum Serotonin Levels in Patients with Opioid Use Disorder Receiving the Opium Tincture Maintenance Treatment
    Shokravian M., Miladi-Gorji H., Shajiee H., Ghorbani R., and Mazinani M.
  • Telemedicine in Addictions: Feasibility Randomised Controlled Trial
    Mayet S., Gledhill A., McCaw I., Hashmani Z., Drozdova Z., Arshad S., Shahbaz S., Huang C., and Phillips T.
  • Cocaine Use in Opioid and Alcohol Substance Use Disorders
    Pacini M., Della Rocca F., Maremmani A.G.I., and Maremmani I.

 

Cover

Vol. 25 • Na. N4 • August 2023

In this issue:

  • Characteristics of opioid-dependent patients choosing antagonist treatment with extended-release naltrexone compared with patients in opioid maintenance treatment in Norway
    Weimand B., Karlsson A.T., Solli K.K., Vederhus J.-K., Mordal J., Wergeland Digranes L., and Tanum L.
  • Evaluating α-synuclein, dopamine and serotonin concentrations in the blood of patients with heroin use disorder: Baseline and post-treatment comparisons
    Yazla E., Cetin I., and Kayadibi H.
  • Exposure and addiction rates to substances and behaviours among Israeli university students
    Snits A., Rozner L., Shoshan S., and Peles E.
  • Differences in the time needed for solid versus liquid delivery of methadone for patients with Opioid Use Disorder in Italy: The SO.LI.D.O 2 study
    Bruno G.M., Caruggi M., Ciccarone A., Valentino M.C., Ariano V., De Fazio S., Leonardi C., Ventre G., Riglietta M., Somaini L., Corbetta Andrea for the SO.LI.D.O. 2 Group, and Colombo G.L.
  • Trends of hospital admissions for alcohol, cannabinoids, benzodiazepines and heroin-related intoxications among children, adolescents and young adults in Slovenia in the years 1999–2019 and the possible impact of economic crisis
    Lovrecic B., Lovrecic M., Simon M.R., Korosec A., Stibernik M., and Maremmani A.G.I.

 

Cover

Vol. 25 • Na. N5 • October 2023

In this issue:

  • An uncontrolled pilot trial of a buprenorphine dispensing device to enhance outpatient treatment for opioid use disorder
    Wenzel K., Thomas J., Davis M., Saenko M., Ervin M., Machineni P., Rudin L., and Fishman M.
  • Electrocardiogram and Liver Function Changes in Methadone Maintenance Treatment After Heroin Use
    Hu H., Lu D., Xie R., Zhong S., Cao S., and Liu L.
  • Predictors of relapse following institutional drug rehabilitation among male drug addicts in selected rehabilitation centres in Sri Lanka – A nested case-control study
    Darshana N., Wijesinghe C., and De Silva V.
  • The role of economic, social and occupational factors in relapse among patients with methadone maintenance treatment (MMT): A descriptive-analytical study
    Motazedian S., Kheradmand A., Badiei R., Babazadehdezfoly A., and Keshavarzi A.
  • Is mothers' cocaine use associated with poorer quality of feeding interactions with their offspring?
    Cerniglia L., Maremmani A.G.I., and Cimino S.

 

Cover

Vol. 25 • Na. N6 • December 2023

In this issue:

  • Prevalence of Attention Deficit Hyperactivity Disorder in Adults Individuals with Addiction Disorders
    Auriemma F., Direnzo G.F.M., Pero D., Boccassi L., Carbone V., Cefalo G., Cervelli C., Colurcio B., Costrini P., Cortese E., Davide C., Forino G., Garofano R., Maione F., Marguccio E., Navarra A., Nunzi M., Pirrotta F., Pizzirusso A., Scarpino V., Tulino
  • Patients on buprenorphine maintenance treatment. Cannabis and amphetamine use
    Simonovska N., Velikj Stefanovska V., Bekarovski N., Petkovska L., Pereska Z., Babulovska A., and Kostovski D.
  • Are urine tests within opioid agonist treatment a justified practice?
    Baud C.-A., Schmitt-Koopmann C., Junod V., Dickson C., Brülisauer L., Broers B., and Simon O.
  • Comparing the Effectiveness of Emotion-focused Therapy and Schema Therapy in Impulsivity, Shame, and Self-blame in Addicts on Methadone Maintenance Treatment: A Clinical Trial Study
    Salasi B., Ramezani M.A., Jahan F., and Kordbagheri M.
  • Addressing Illicit Drug Use and Mental Health in Prisons: Insights and Recommendations from International Studies
    Wei L.

 

 

EUROPAD - European Opiate Addiction Treatment Association
Brussels, Belgium, EU
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page